PATENT CLAIM ANALYSIS

Application Number: 16116282
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["424", "490000"]

Abstract:
A tamper-resistant pharmaceutical dosage form comprising a multitude of particles which comprise a pharmacologically active compound, a polyalkylene oxide, and a disintegrant; wherein the pharmacologically active compound is dispersed in a matrix comprising the polyalkylene oxide and the disintegrant; wherein the content of the disintegrant is more than 5.0 wt.-%, based on the total weight of the pharmaceutical dosage form and/or based on the total weight of the particles; wherein the content of the polyalkylene oxide is at least 25 wt.-%, based on the total weight of the pharmaceutical dosage form and/or based on the total weight of the particles; and wherein the dosage form provides under in vitro conditions immediate release of the pharmacologically active compound in accordance with Ph. Eur.

Claim (Index 6):
The pharmaceutical dosage form according to  claim 4 , wherein the disintegrant is or comprises a starch derivative; and/or the starch derivative is sodium starch glycolate or sodium carboxymethyl starch.

Metadata:
- Claim Count in Document: 74.0
- Percentile: 96.0
- Lexical Diversity: 2.57692
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15169778', '14287512', '13559644', '15166573', '14979888']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7431663107395965
- 35 USC 102 Novelty (BERT): 0.5360645772841772
- Combined Prediction Score: 0.7224561373940547
- Mean Citation Score: 305.162254
- Max Citation Score: 377.9201
- Similarity Product: 257.4886040904164

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test